Pioneering Cold Isotope Metallomics
Developing proprietary disease-modifying drugs designed to activate neurogenesis
About Nomax Pharma
Our Innovation
We are leading the development of innovative therapies based on proprietary isotope-selective modulation ISM (tm) platform, designed to activate disease-modifying mechanisms that slow-down and potentially reverse neurodegeneration.
We Work with Metallome Connecting the "Omes"
The metallome is intricately connected to other "omes" such as the genome, proteome, microbiome, and more, influencing and being influenced by those biological systems through its role in essential metal ion regulation and interactions.
The metallome encompasses the distribution of metal ions within tissues and celles, and is critical for a myriad of biological processes, including the synthesis of amino acids and proteins, maintaining charge balance and electrolyte function, ensuring DNA integrity and facilitating its repair, as well as playing a key role in structure, signaling, and stem cell functionality. Our drug candidates are designed to stimulate the fundamental biological activities of the metallome to re-establish a state of healthy homeostasis.
Our ISM(tm) Drug Development Platform
At the intersection of metallomics and drug development, our core expertise lies in Isotope-Selective Modulation ISM(tm). We harness the power of ISM(tm) platform to pioneer the treatments that not only target the underlying cascades of neurodegenerative diseases, but also promote the regeneration of neural cells and tissues, all while maintaining a steadfast commitment to patient safety.
Revolutionizing Biotechnology at Nomax Pharma
Nomax emerged to revolutionize neurology with our distinctive scientific perspective on disease pathogenesis. Our approach is rooted in over ten years of research that delves deeper than molecular patterns, exploring the isotopic signatures at the atomic level within cells and tissues as part of metalloproteomics.
Harnessing Cold Isotopes For Multi-Omic Health
Metallomics Is The Frontier of Biotech Innovations
Nomax Pharma - a Vanguard in Metalloproteomics Medicines
Metallomics integrates chemistry, biology, physics, and medicine focusing on the roles of metals in biological systems. It examines the metallome - the full spectrum of metals withing cells and organisms - using advanced mass spectrometry to uncover metal concentrations, distributions, and interactions. Metallome is crucial for understanding diseases linked to metal imbalances, such as neurodegenerative disorders, and for exploring the fundamental processes of life.
Our Team
Max Temnik, PhD
Santosh Kesari, MD, PhD
Sergei Petukhov, DVM
Founder, President & CSO
Chemistry & Business
Sergei Petukhov, DVM
Santosh Kesari, MD, PhD
Sergei Petukhov, DVM
Co-Founder & CEO
Biotech & Venture Capital
Santosh Kesari, MD, PhD
Santosh Kesari, MD, PhD
Santosh Kesari, MD, PhD
Co-Founder & CMO
Medicine & Molecular Biology
Sergei Gurin, MBA
Santosh Kesari, MD, PhD
Santosh Kesari, MD, PhD
Co-Founder, VP & CFO
Nuclear Physics & Finance